>
Switch to:

Turning Point Therapeutics PS Ratio

: 123.07 (As of Today)
View and export this data going back to 2019. Start your Free Trial

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Turning Point Therapeutics's share price is $72.980000. Turning Point Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $0.59. Hence, Turning Point Therapeutics's PS Ratio for today is 123.07.

Good Sign:

Turning Point Therapeutics Inc stock PS Ratio (=123.15) is close to 1-year low of 119.9

NAS:TPTX' s PS Ratio Range Over the Past 10 Years
Min: 119.9   Med: 186.17   Max: 225.36
Current: 122.56

119.9
225.36

During the past 4 years, Turning Point Therapeutics's highest PS Ratio was 225.36. The lowest was 119.90. And the median was 186.17.

NAS:TPTX's PS Ratio is ranked lower than
78% of the 950 Companies
in the Biotechnology industry.

( Industry Median: 21.19 vs. NAS:TPTX: 122.56 )

Turning Point Therapeutics's Revenue per Sharefor the three months ended in Dec. 2020 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $0.59.

Back to Basics: PS Ratio


Turning Point Therapeutics PS Ratio Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.

* Premium members only.

Turning Point Therapeutics Annual Data
Dec17 Dec18 Dec19 Dec20
PS Ratio 0.00 0.00 0.00 205.48

Turning Point Therapeutics Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
PS Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 205.48

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Turning Point Therapeutics PS Ratio Distribution

* The bar in red indicates where Turning Point Therapeutics's PS Ratio falls into.



Turning Point Therapeutics PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Turning Point Therapeutics's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=72.980000/0.593
=123.07

Turning Point Therapeutics's Share Price of today is $72.980000.
Turning Point Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0.593 (Sep. 2020 ) + 0 (Dec. 2020 ) = $0.59.

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Turning Point Therapeutics  (NAS:TPTX) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Turning Point Therapeutics PS Ratio Related Terms


Turning Point Therapeutics PS Ratio Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)